Huntington National Bank’s NxStage Medical Inc. NXTM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $30 | Hold |
1
| – | – | ﹤0.01% | 3234 |
|
|
2025
Q4 | $30 | Hold |
1
| – | – | ﹤0.01% | 3148 |
|
|
2025
Q3 | $30 | Hold |
1
| – | – | ﹤0.01% | 3196 |
|
|
2025
Q2 | $30 | Hold |
1
| – | – | ﹤0.01% | 3224 |
|
|
2025
Q1 | $30 | Hold |
1
| – | – | ﹤0.01% | 3253 |
|
|
2024
Q4 | $30 | Hold |
1
| – | – | ﹤0.01% | 3276 |
|
|
2024
Q3 | $30 | Hold |
1
| – | – | ﹤0.01% | 3264 |
|
|
2024
Q2 | $30 | Hold |
1
| – | – | ﹤0.01% | 3222 |
|
|
2024
Q1 | $30 | Hold |
1
| – | – | ﹤0.01% | 3082 |
|
|
2023
Q4 | $30 | Hold |
1
| – | – | ﹤0.01% | 2976 |
|
|
2023
Q3 | $30 | Hold |
1
| – | – | ﹤0.01% | 2960 |
|
|
2023
Q2 | $30 | Hold |
1
| – | – | ﹤0.01% | 2932 |
|
|
2023
Q1 | $30 | Hold |
1
| – | – | ﹤0.01% | 2781 |
|
|
2022
Q4 | $30 | Hold |
1
| – | – | ﹤0.01% | 2647 |
|
|
2022
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 2627 |
|
|
2022
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 2631 |
|
|
2022
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 2558 |
|
|
2021
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 2485 |
|
|
2021
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 2211 |
|
|
2021
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 2100 |
|
|
2021
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 1990 |
|
|
2020
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 1967 |
|
|
2020
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 1912 |
|
|
2020
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 1926 |
|
|
2020
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 2020 |
|
|
2019
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 2033 |
|
|
2019
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 1938 |
|
|
2019
Q2 | $0 | Buy |
+1
| New | – | ﹤0.01% | 1969 |
|
|
2019
Q1 | – | Sell |
-1
| Closed | – | – | 1961 |
|
|
2018
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 2014 |
|
|
2018
Q3 | $0 | Buy |
+1
| New | +$28 | ﹤0.01% | 2006 |
|
|
2016
Q2 | – | Sell |
-1,250
| Closed | -$22K | – | 1766 |
|
|
2016
Q1 | $22K | Buy |
+1,250
| New | +$20.9K | ﹤0.01% | 1338 |
|
|
2015
Q3 | – | Sell |
-500
| Closed | -$7K | – | 1837 |
|
|
2015
Q2 | $7K | Sell |
500
-750
| -60% | -$12.7K | ﹤0.01% | 1554 |
|
|
2015
Q1 | $22K | Sell |
1,250
-800
| -39% | -$14.1K | ﹤0.01% | 1343 |
|
|
2014
Q4 | $37K | Buy |
+2,050
| New | +$33K | ﹤0.01% | 1195 |
|
|
2014
Q1 | – | Sell |
-1,000
| Closed | -$10K | – | 1676 |
|
|
2013
Q4 | $10K | Buy |
+1,000
| New | +$11.3K | ﹤0.01% | 1447 |
|
Huntington National Bank's NXTM Position: Q1 2026 in Review
Huntington National Bank held its NxStage Medical Inc. (NXTM) position steady in Q1 2026 at 1 share worth $30. The position accounts for ﹤0.01% of the portfolio, ranked #3234.
Huntington National Bank first reported a position in NXTM in Q4 2013 and has held it in 35 quarters since. The position peaked at $37K in Q4 2014. 1 fund tracked by Wall St. Rank holds NXTM as of Q1 2026.
- Huntington National Bank held 1 share of NxStage Medical Inc. worth $30 as of Q1 2026.
- Huntington National Bank left its NxStage Medical Inc. share count unchanged in Q1 2026.
- NxStage Medical Inc. made up ﹤0.01% of Huntington National Bank's portfolio in Q1 2026, its #3234 holding.
- Huntington National Bank first reported a position in NxStage Medical Inc. in Q4 2013 and has held it in 35 quarters since.
- Huntington National Bank's NxStage Medical Inc. position peaked at $37K in Q4 2014.
- 1 fund tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2026.
Based on Huntington National Bank's 13F filing for Q1 2026, filed 15 May 2026.